Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
22 March 2021Website:
http://brightmindsbio.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 23:43:49 GMTDividend
Analysts recommendations
Institutional Ownership
DRUG Latest News
FDA confirms the favorable benefit-risk profile of WAKIX Harmony Biosciences focused on continuing to advance its pipeline assets across three rare CNS franchises; anticipates at least one new product or indication launch annually over the next five years PLYMOUTH MEETING, Pa. , June 25, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that the U.S. Food and Drug Administration denied the Citizen Petition filed by a short seller claiming that WAKIX is not safe and effective for the treatment of excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy.
PLYMOUTH MEETING, Pa. , June 24, 2024 /PRNewswire/ -- Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for WAKIX® (pitolisant) tablets for the treatment of excessive daytime sleepiness (EDS) in pediatric patients 6 years of age and older with narcolepsy.
AGOURA HILLS, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will speak at the 20th Annual Congress of International Drug Discovery Science & Technology (IDDST) (Europe), June 17-19, 2024 at Budapest, Hungary.
Penny stocks under $1 to watch this week. The post Penny Stocks To Buy?
What type of business is Bright Minds Biosciences?
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
What sector is Bright Minds Biosciences in?
Bright Minds Biosciences is in the Healthcare sector
What industry is Bright Minds Biosciences in?
Bright Minds Biosciences is in the Biotechnology industry
What country is Bright Minds Biosciences from?
Bright Minds Biosciences is headquartered in United States
When did Bright Minds Biosciences go public?
Bright Minds Biosciences initial public offering (IPO) was on 22 March 2021
What is Bright Minds Biosciences website?
https://brightmindsbio.com
Is Bright Minds Biosciences in the S&P 500?
No, Bright Minds Biosciences is not included in the S&P 500 index
Is Bright Minds Biosciences in the NASDAQ 100?
No, Bright Minds Biosciences is not included in the NASDAQ 100 index
Is Bright Minds Biosciences in the Dow Jones?
No, Bright Minds Biosciences is not included in the Dow Jones index
When does Bright Minds Biosciences report earnings?
Next earnings report date is not announced yet